Download presentation
Presentation is loading. Please wait.
Published byMavis Dalton Modified over 6 years ago
1
Use of hemodialysis and hemoperfusion in poisoned patients
William J. Holubek, Robert S. Hoffman, David S. Goldfarb, Lewis S. Nelson Kidney International Volume 74, Issue 10, Pages (November 2008) DOI: /ki Copyright © 2008 International Society of Nephrology Terms and Conditions
2
Figure 1 Summary of analysis of TESS data. HD, hemodialysis; HP, charcoal hemoperfusion; PD, peritoneal dialysis. Kidney International , DOI: ( /ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
3
Figure 2 Normalized number of cases receiving hemodialysis and hemoperfusion. Kidney International , DOI: ( /ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
4
Figure 3 Normalized number of cases receiving peritoneal dialysis. Peritoneal dialysis was no longer recorded in TESS after 1992. Kidney International , DOI: ( /ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
5
Figure 4 Trends for the most commonly accepted indications for hemodialysis and/or hemoperfusion. Kidney International , DOI: ( /ki ) Copyright © 2008 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.